Article
Small-cell carcinoma with an epidermal growth factor receptor mutation in a never-smoker with gefitinib-responsive adenocarcinoma of the lung.
Clinical lung cancer - 1 Sept 2010
Alam Naheed, Gustafson Karen S, Ladanyi Marc, Zakowski Maureen F, Kapoor Atul, Truskinovsky Alexander M, Dudek Arkadiusz Z
Abstract excerpt
Activating mutations in the epidermal growth factor receptor (EGFR) gene are extremely rare in small-cell lung cancer (SCLC). Here, we present a case of an EGFR-mutant gefitinib-responsive non-small-cell lung cancer (NSCLC) of adenocarcinoma histology occurring in a never-smoker followed by subsequent diagnosis of metastatic SCLC carrying an EGFR mutation. Although gefitinib therapy of the primary NSCLC resulted...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
